Skip to main content

Research Repository

Advanced Search

Drug resistance in Medulloblastoma is driven by YB-1, ABCB1 and a seven-gene drug signature (2023)
Journal Article
Taylor, L., Wade, P., Johnson, J., Aldighieri, M., Morlando, S., Di Leva, G., …Coyle, B. (in press). Drug resistance in Medulloblastoma is driven by YB-1, ABCB1 and a seven-gene drug signature. Cancers, 15(4), 1086. https://doi.org/10.3390/cancers15041086

Therapy resistance represents an unmet challenge in the treatment of medulloblastoma. Accordingly, the identification of targets that mark drug-resistant cell populations, or drive the proliferation of resistant cells, may improve treatment strategie... Read More about Drug resistance in Medulloblastoma is driven by YB-1, ABCB1 and a seven-gene drug signature.